Research & Development
-
Pandemic risks will shape treasury strategy
Discover how pandemic risks are redefining the priorities and strategies of today’s corporate treasurers. This new EIU report reveals which threats top the agenda, how treasury leaders are responding, and what skills and technologies are becoming essential for the future.
-
Unilever and Evonik collaboration ensures a green and clean future
Unilever’s partnership with Evonik paves the way for greener, cleaner home care products by shifting to innovative biosurfactants and circular packaging. Discover how this collaboration is set to transform everyday cleaning while supporting a sustainable future—find out what’s coming next.
-
New coating reduces chances of virus transmission through printed media
Discover how a breakthrough water-based coating kills up to 99.9% of bacteria on printed media, offering safer magazines, menus, and packaging. Learn how Epple Druckfarben’s Finishfit Microbe Protect 2400 can help protect your business and your customers—explore the science behind this innovative new solution.
-
Betadine products prove 99.99% effective against COVID-19
Betadine’s trusted range—including Mouthwash and Gargle—has been proven to kill 99.99% of the SARS-CoV-2 virus in seconds, according to international lab studies. Discover how these products can help protect your family and practice.
-
New web-based training from Alec Cameron
Discover Alec Cameron’s new web-based training platform—offering top-quality, affordable courses trusted by South Africa’s FMCG leaders for over 25 years. Explore how you can access expert-driven skills development, anywhere and anytime.
-
Gilead, AstraZeneca and Pfizer likely to win the COVID-19 treatment development race
Gilead, AstraZeneca and Pfizer are leading the race to develop effective COVID-19 treatments, with Gilead’s remdesivir standing out for its proven results. Discover how these pharma giants are shaping the future of pandemic response.
-
Givaudan acquires French biotechnology company
Givaudan has acquired innovative French biotech company Alderys, strengthening its expertise in bio-engineering and sustainable solutions for the chemical, cosmetic, and nutrition industries. This move expands Givaudan’s portfolio of natural, bio-sourced products—discover how this acquisition supports their long-term growth and commitment to sustainability.
-
Asymptomatic testing will be vital in next phase of COVID-19 pandemic
With virus resurgence a growing concern, expanding COVID-19 testing to include asymptomatic individuals is now crucial. Discover why experts believe this shift will play a vital role in controlling future outbreaks and how new FDA approvals are driving rapid change in global testing strategies.
